References
- Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu
CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K,
Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Cancer
susceptibility gene mutations in individuals with colorectal cancer. J
Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012
- https://www.cancer.net/cancer-types/familial-adenomatous-polyposis
- Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T,
Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C;
Gastrointestinal Consortium Panel. Colorectal cancer screening and
surveillance: clinical guidelines and rationale. Update based on new
evidence. Gastroenterology. 2003 Feb;124(2):544-60. doi:
10.1053/gast.2003.50044
- Vitellaro M, Bonfanti G, Sala P, Poiasina E, Barisella M, Signoroni S,
Mancini A, Bertario L. Laparoscopic colectomy and restorative
proctocolectomy for familial adenomatous polyposis. Surg Endosc. 2011
Jun;25(6):1866-75. doi: 10.1007/s00464-010-1478-z
- Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC,
Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H; CGC, Ness RM,
Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall
MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ,
Mikkelson J; CGC, Peter S, Regenbogen SE, Dwyer MA; CGC, Ogba N. NCCN
Guidelines Insights: Genetic/Familial High-Risk Assessment:
Colorectal, Version 2.2019. J Natl Compr Canc Netw. 2019 Sep
1;17(9):1032-1041. doi: 10.6004/jnccn.2019.0044
- Nosé V. Familial Cancer Syndromes in Diagnostic Pathology: E-Book –
2020; 719
- Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford
SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister
SM. Medulloblastoma. Nat Rev Dis Primers. 2019 Feb 14;5(1):11. doi:
10.1038/s41572-019-0063-6
- Roussel MF, Hatten ME. Cerebellum development and medulloblastoma.
Curr Top Dev Biol. 2011;94:235-82. doi:
10.1016/B978-0-12-380916-2.00008-5
- Northcott PA, Dubuc AM, Pfister S, Taylor MD. Molecular subgroups of
medulloblastoma. Expert Rev Neurother. 2012 Jul;12(7):871-84. doi:
10.1586/ern.12.66
- Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S,
Manie E, Raquin MA, Bours D, Carpentier S, Barillot E, Grill J, Doz F,
Puget S, Janoueix-Lerosey I, Delattre O. Beta-catenin status in
paediatric medulloblastomas: correlation of immunohistochemical
expression with mutational status, genetic profiles, and clinical
characteristics. J Pathol. 2009 May;218(1):86-9
- Phoenix TN, Patmore DM, Boop S, et al. : Medulloblastoma Genotype
Dictates Blood Brain Barrier Phenotype. Cancer Cell. 2016;29:508–22.
10.1016/j.ccell.2016.03.002
- https://clinicaltrials.gov/ct2/show/study/NCT02066220
- https://clinicaltrials.gov/ct2/show/NCT01878617
- Patay Z, DeSain LA, Hwang SN, Coan A, Li Y, Ellison DW. MR imaging
characteristics of wingless-type-subgroup pediatric medulloblastoma.
AJNR Am J Neuroradiol. 2015 Dec;36(12):2386-93. doi:
10.3174/ajnr.A4495
- Surun A, Varlet P, Brugières L, Lacour B, Faure-Conter C, Leblond P,
Bertozzi-Salomon AI, Berger C, André N, Sariban E, Raimbault S, Prieur
F,Desseigne F, Zattara H, Guimbaud R, Polivka M, Delisle MB,
Vasiljevic A, MaurageCA, Figarella-Branger D, Coulet F,
Guerrini-Rousseau L, Alapetite C, Dufour C,Colas C, Doz F, Bourdeaut
F. Medulloblastomas associated with an APC germline pathogenic variant
share the good prognosis of CTNNB1-mutated medulloblastomas. Neuro
Oncol. 2020 Jan 11;22(1):128-138. doi: 10.1093/neuonc/noz154
- Massimino M, Sunyach MP, Barretta F, Gandola L, Garegnani A, Pecori E,
Spreafico F, Bonneville-Levard A, Meyronet D, Mottolese C, Boschetti
L, Biassoni V, Schiavello E, Giussani C, Carrabba G, Diletto B,
Pallotti F, Stefini R, Ferrari A, Terenziani M, Casanova M, Luksch R,
Meazza C, Podda M, Chiaravalli S, Puma N, Bergamaschi L, Morosi C,
Calareso G, Giangaspero F, Antonelli M, Buttarelli FR, Frappaz D.
Reduced-dose craniospinal irradiation is feasible for standard-risk
adult medulloblastoma patients. J Neurooncol. 2020 Jun 21.
doi:10.1007/s11060-020-03564-y
- Khattab A, Monga DK. Turcot syndrome. [Updated 2020 Jun 29]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls
Publishing; 2020 Jan-.
- Crawford JR, MacDonald TJ, Packer RJ. Medulloblastoma in childhood:
new biological advances. Lancet Neurol. 2007 Dec;6(12):1073-85. doi:
10.1016/S1474-4422(07)70289-2
- Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH,
Witjes MJ, Links TP, van Beek AP. Extra-intestinal manifestations of
familial adenomatous polyposis. Ann Surg Oncol. 2008
Sep;15(9):2439-50. doi: 10.1245/s10434-008-9981-3
- Zurawel RH, Chiappa SA, Allen C, Raffel C. Sporadic medulloblastomas
contain oncogenic beta-catenin mutations. Cancer Res. 1998 Mar
1;58(5):896-9
- Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of
beta-catenin in medulloblastomas. J Neuropathol Exp Neurol. 2000
Apr;59(4):333-7. doi: 10.1093/jnen/59.4.333
- Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues
P, Ohgaki H. APC mutations in sporadic medulloblastomas. Am J Pathol.
2000 Feb;156(2):433-7. doi: 10.1016/S0002-9440(10)64747-5
- Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sörensen N, Berthold F,
Behrens J, Birchmeier W, Wiestler OD, Pietsch T. Deletions of AXIN1, a
component of the WNT/wingless pathway, in sporadic medulloblastomas.
Cancer Res. 2001 Oct 1;61(19):7039-43
- Koch A, Waha A, Tonn JC, Sörensen N, Berthold F, Wolter M,
Reifenberger J, Hartmann W, Friedl W, Reifenberger G, Wiestler OD,
Pietsch T. Somatic mutations of WNT/wingless signaling pathway
components in primitive neuroectodermal tumors. Int J Cancer. 2001 Aug
1;93(3):445-9. doi: 10.1002/ijc.1342
- Baeza N, Masuoka J, Kleihues P, Ohgaki H. AXIN1 mutations but not
deletions in cerebellar medulloblastomas. Oncogene. 2003 Jan
30;22(4):632-6. doi: 10.1038/sj.onc.1206156
- Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner
S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M,
Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang
M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C,
Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser
P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM,
Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel
AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T,
Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz
J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim
K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S,
Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D,
Zhang J, Solomon DA, MarraM, Eils R, Bartram CR, von Hoff K, Rutkowski
S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P,
Malkin D, Gajjar A, Korbel JO, Pfister SM. Spectrum and prevalence of
genetic predisposition in medulloblastoma: a retrospective genetic
study and prospective validation in a clinical trial cohort. Lancet
Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0
- Silva R, Marie SK, Uno M, Matushita H, Wakamatsu A, Rosemberg S.
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma
variants. Clinics 2013;68(2):167-172
- Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M,
Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho
YJ, Yeom KW. MRI surrogates for molecular subgroups of
medulloblastoma. AJNR Am J Neuroradiol. 2014 Jul;35(7):1263-9. doi:
10.3174/ajnr.A399
- Kim B, Tabori U, Hawkins C. An update on the CNS manifestations of
brain tumor polyposis syndromes. Acta Neuropathol. 2020
Apr;139(4):703-715. doi: 10.1007/s00401-020-02124-y
- Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH,
Witjes MJ, Links TP, van Beek AP. Extra-intestinal manifestations of
familial adenomatous polyposis. Ann Surg Oncol. 2008
Sep;15(9):2439-50. doi: 10.1245/s10434-008-9981-3
- Nobre L, Zapotocky M, Khan S, Fukuoka K, Fonseca A, McKeown T,
Sumerauer D, Vicha A, Grajkowska WA, Trubicka J, Li KKW, Ng HK,
Massimi L, Lee JY, Kim SK, Zelcer S, Vasiljevic A, Faure-Conter C,
Hauser P, Lach B, van Veelen-Vincent ML, French PJ, Van Meir EG, Weiss
WA, Gupta N, Pollack IF, Hamilton RL, Nageswara Rao AA, Giannini C,
Rubin JB, Moore AS, Chambless LB, Vibhakar R, Ra YS, Massimino M,
McLendon RE, Wheeler H, Zollo M, Ferruci V, Kumabe T, Faria CC, Sterba
J, Jung S, López-Aguilar E, Mora J, Carlotti CG, Olson JM, Leary S,
Cain J, Krskova L, Zamecnik J, Hawkins CE, Tabori U, Huang A, Bartels
U, Northcott PA, Taylor MD, Yip S, Hansford JR, Bouffet E, Ramaswamy
V. Pattern of Relapse and Treatment Response in WNT-Activated
Medulloblastoma. Cell Rep Med 2020;1:100038. doi:
10.1016/j.xcrm.2020.100038
- Rosenberg MM, Yang F, Giovanni M, Mohn JL, Temburni MK, Jacob MH.
Adenomatous polyposis coli plays a key role, in vivo, in coordinating
assembly of the neuronal nicotinic post synaptic complex. Mol Cell
Neurosci 2008;38:138–52
Cruz-Correa MR, Sala AC, Cintrón B, Hernández J, Olivera M, Cora A,
Moore CM, Luciano CA, Soto-Salgado M, Giardiello FM, Hooper SR.
Ubiquitous neurocognitive dysfunction in familial adenomatous polyposis:
proof-of-concept of the role of APC protein in neurocognitive function.
Hered Cancer Clin Pract. 2020;18:4. doi: 0.1186/s13053-020-0135-3